ReviewFrontiers in cellular and infection microbiology2025
Current perspectives on alphavirus encapsidation, assembly and budding.
Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alphaviruses are an escalating global concern due to their considerable clinical impact and expanding geographic distribution. Transmitted primarily through the bites of infected mosquitoes, alphaviruses cause a wide spectrum of arthritogenic and encephalitic diseases in both humans and animals. Their ability to re-emerge with enhanced fitness through adaptive mutations further underscores their public health importance. Despite advances in antiviral discovery and vaccine development, no licensed therapies are available for most of them, and vector control can only be partially effective. These limitations underscore the need for a mechanistic understanding of the virus life cycle to guide rational intervention strategies. Deciphering the molecular mechanisms of alphavirus assembly and budding has been a central research frontier. This perspective brings together the research on viral RNA encapsidation, structural elucidation of virus architecture, and the essential functions of host factors, membranes, and cytoskeletal components. An integrated understanding of the roles of both viral and host factors, along with the spatial and temporal coordination of events throughout the viral life cycle, is crucial for addressing key mechanistic gaps and for guiding the development of next-generation antiviral and vaccine strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.